Vera Therapeutics, Inc. (VERA) Misses Q2 EPS by 38c
Tweet
Share
E-mailGet Alerts VERA Hot Sheet
Price: $34.08 -0.32%
Financial Fact:
Total Net Revenues: 3.85M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Financial Fact:
Total Net Revenues: 3.85M
Today's EPS Names:
HMR, RZLV, ZEPP, More
Join SI Premium – FREE
Vera Therapeutics, Inc. (NASDAQ: VERA) reported Q2 EPS of ($1.20), $0.38 worse than the analyst estimate of ($0.82).
For earnings history and earnings-related data on Vera Therapeutics, Inc. (VERA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
- Ideaya Biosciences (IDYA) Reiterated at Market Outperform by Citizens on IDE849 Advances
- UBS Starts Assembly Biosciences (ASMB) at Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
